Ros­ter of ex­perts for Deng­vaxia deaths

Sun.Star Davao - - TOP STORIES - By Juliet C. Re­vita

HEALTH Sec­re­tary Fran­cisco Duque said a list of health ex­perts will in­ves­ti­gate the con­tro­ver­sial Deng­vaxia vac­cine.

“The Of­fice of the Pres­i­dent meron na silang lis­ta­han of the panel of ex­perts that will fi­nally say what re­ally caused the deaths of the 117 vac­ci­nees,” Duque said in an in­ter­view.

This de­vel­oped fol­low­ing the con­flict­ing find­ings of ex­perts com­ing from dif­fer­ent stake­hold­ers. These ex­perts were rec­om­mended by the Depart­ment of Health (DOH) to con­duct the in­ten­sive study on the Deng­vaxia mess.

“Maram­ing causes ng deaths. Ang po­si­tion ng Univer­sity of the Philip­pines-PGH (Philip­pine Gen­eral Hos­pi­tal) is the deaths could have been caused by ei­ther, con­gen­i­tal heart dis­eases to in­clude, pneu­mo­nia, CNS (cen­tral ner­vous sys­tem) in­fec­tions, leukemia, can­cer,” Duque added.

He also de­bunked the in­for­ma­tion be­ing spread by the ex­perts from the Pub­lic At­tor­ney’s Of­fice (PAO) who con­ducted a probe on the deaths that it is caused by the Deng­vaxia vac­cine in­jected on the vic­tims.

“That’s the the­ory that is be­ing pro­pounded by the pub­lic at­tor­ney’s of­fice but they bet­ter just be good lawyers than pre­tend­ing to be doc­tors,” he said.

Duque main­tained that based on the in­ves­ti­ga­tion con­ducted by UP-PGH Deng­vaxia In­ves­tiga­tive Task Force, the deaths are at­trib­uted to the ill­nesses that the pa­tients had al­ready been suf­fer­ing.

“They are also say­ing that per­haps, if there is any­thing to do with Deng­vaxia, it is prob­a­bly be­cause of vac­cine fail­ure hindi nabi­gay ng sapat na pro­tec­tion yong Deng­vaxia. Kaya nong nagka­roon ng dengue sila at nagka­roon ng parang sec­ondary in­fec­tion don nagka­roon ng se­vere dengue na tinatawag,” he added.

On De­cem­ber 1, 2017, Duque is­sued a hold or­der and sus­pended the mas­sive dengue im­mu­niza­tion pro­gram fol­low­ing the ad­mis­sion of the man­u­fac­turer Sanofi Pas­teur that the dengue vac­cine posed risky se­vere symp­toms for in­di­vid­u­als who were not pre­vi­ously in­fected by the dengue virus.

Newspapers in English

Newspapers from Philippines

© PressReader. All rights reserved.